Provided by Tiger Trade Technology Pte. Ltd.

uniQure NV

26.05
+0.40001.56%
Pre-market: 25.96-0.0900-0.35%06:47 EST
Volume:1.34M
Turnover:34.68M
Market Cap:1.62B
PE:-6.00
High:26.50
Open:25.54
Low:25.01
Close:25.65
52wk High:71.50
52wk Low:7.76
Shares:62.29M
Float Shares:40.64M
Volume Ratio:0.52
T/O Rate:3.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3443
EPS(LYR):-4.9242
ROE:-165.27%
ROA:-13.89%
PB:7.09
PE(LYR):-5.29

Loading ...

uniQure Price Target Maintained With a $70.00/Share by HC Wainwright & Co.

Dow Jones
·
17 mins ago

How Early AMT-191 Gene Therapy Signals Will Impact uniQure (QURE) Investors

Simply Wall St.
·
Yesterday

Early uniQure Fabry Trial Shows Lasting Enzyme Boost, Safety Watch

Benzinga_recent_news
·
Feb 07

uniQure präsentiert neue Phase-I/IIa-Daten zur Gentherapie AMT-191 bei Fabry-Krankheit

Reuters
·
Feb 06

uniQure Reports Sustained Enzyme Increases in Phase I/IIa Fabry Disease Gene Therapy Trial

Reuters
·
Feb 06

A Look At uniQure (QURE) Valuation After FDA Setback And Legal Investigations

Simply Wall St.
·
Feb 04

uniQure Initiated at Equal-Weight by Barclays

Dow Jones
·
Jan 28

Barclays Initiates Coverage on uniQure N.V With Equal Weight Rating, $31 Price Target

MT Newswires Live
·
Jan 28

uniQure initiated with an Equal Weight at Barclays

TIPRANKS
·
Jan 28

uniQure NV Director Robert Gut Reports Disposal of Common Shares

Reuters
·
Jan 15

uniQure Showcases Gene Therapy Leadership and Pipeline Progress in New Corporate Presentation

Reuters
·
Jan 13

uniQure NV Director Jack Kaye Reports Disposal of Common Shares

Reuters
·
Jan 13

uniQure Stock Jumps After Scheduling FDA Type A Meeting For AMT‑130 Approval Pathway

Benzinga
·
Jan 10

US-Listed Shares of Uniqure Rise 13% Premarket as FDA Review Talks Revive Hopes for Huntington's Therapy

THOMSON REUTERS
·
Jan 09

BUZZ-UniQure rises as US FDA review talks revive hopes for Huntington's therapy

Reuters
·
Jan 09

uniQure announces Type A meeting scheduled with FDA

TIPRANKS
·
Jan 09

Does uniQure (QURE) FDA Feedback on AMT-130 Reframe Its Risk, Funding and Strategy Profile?

Simply Wall St.
·
Dec 18, 2025

uniQure call volume above normal and directionally bullish

TIPRANKS
·
Dec 17, 2025

What's Going On With uniQure Stock On Tuesday?

Benzinga
·
Dec 17, 2025

uniQure Is Maintained at Buy by Chardan Capital

Dow Jones
·
Dec 05, 2025